Satellos submits SAT-3247 IND to FDA for phase 2 study in children with Duchenne muscular dystrophy | Image credit: Contemporary Pediatrics
On September 22, 2025, Satellos Bioscience submitted an Investigational New Drug (IND) application to the…
Satellos submits SAT-3247 IND to FDA for phase 2 study in children with Duchenne muscular dystrophy | Image credit: Contemporary Pediatrics
On September 22, 2025, Satellos Bioscience submitted an Investigational New Drug (IND) application to the…